Alpha Cognition Inc. Unrealized Gain (Loss) on Derivatives
Alpha Cognition Inc. (ACOG) reported Unrealized Gain (Loss) on Derivatives of -$3.16 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2025-03-31
- Alpha Cognition Inc. unrealized gain (loss) on derivatives for fiscal 2024 was -$3.16M.
- Alpha Cognition Inc. unrealized gain (loss) on derivatives for fiscal 2023 was -$4.09M.
| Period end | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|
| 2024-12-31 | -$3.16M 10-K · filed 2025-03-31 |
| 2023-12-31 | -$4.09M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |